Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)
Condition(s):Low-grade Glioma; Pancreatic CancerLast Updated:December 13, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Low-grade Glioma; Pancreatic CancerLast Updated:December 13, 2023Recruiting
Condition(s):Untreated Advanced or Recurrent Thymic CarcinomasLast Updated:October 23, 2023Recruiting
Condition(s):HER2-positive Breast CancerLast Updated:March 25, 2024Recruiting
Condition(s):Rare Malignant NeoplasmLast Updated:March 22, 2024Recruiting
Condition(s):Cervical Cancer; Ovarian Clear Cell Carcinoma; Nasopharyngeal Carcinoma; Ovarian Cancer; Endometrial Cancer; Triple Negative Breast CancerLast Updated:October 24, 2023Recruiting
Condition(s):Advanced or Recurrent Solid Tumors; FGFR Gene AlterationsLast Updated:January 8, 2024Active, not recruiting
Condition(s):Esophageal Squamous Cell CarcinomaLast Updated:November 9, 2023Recruiting
Condition(s):Locally Advanced Esophageal Squamous Cell CarcinomaLast Updated:November 9, 2023Active, not recruiting
Condition(s):Breast NeoplasmsLast Updated:March 22, 2024Active, not recruiting
Condition(s):Gastric Cancer; Gastroesophageal Junction Region (GEJ) CancerLast Updated:August 21, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.